Tirofiban for recent mild stroke or TIA with narrowed brain artery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You had a mild stroke (NIHSS 5 or less) or a high-risk TIA (ABCD2 score 6 or more) with a narrowed brain artery seen on imaging.
- The study drug can be started within 24 hours of your first symptoms.
- You do not have bleeding problems, kidney or liver failure, or other serious conditions that would make tirofiban unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining a blood-thinning drug (tirofiban) with aspirin can improve recovery after a moderate stroke that started within the last 24 hours. It aims to see if this combination is safe and helps more than aspirin alone.
This trial tests whether giving tirofiban (a blood thinner) shortly after the standard clot-busting drug tenecteplase can improve recovery from a moderate stroke. It is for people who have had a stroke within the last few hours and do not have certain risk factors like irregular heart rhythm or recent bleeding.
This trial tests a medication called tirofiban, which helps prevent blood clots, given after a successful procedure to remove a clot from a large brain artery. The goal is to see if it can reduce disability after a stroke when given within 24 hours of symptom onset.
This trial tests whether a drug called tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It is for strokes caused by a buildup of plaque in a large brain artery, and uses a special MRI to confirm the cause.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
Hear when a new TIA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.